Abbott Laboratories
Symbol: ABT (NYSE)
131.66
▲ (1.77%) 2.296
Company Description:
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Key Stats
- Today's Open: $129.69
- Today's High: $132.641
- Today's Low: $129.115
- Today's Volume: 5.58M
- Yesterday Close: $129.36
- Yesterday High: $131.85
- Yesterday Low: $127.445
- Yesterday Volume: 7.40M
- Last Min Volume: 1
- Last Min High: $131.694
- Last Min Low: $131.656
- Last Min VWAP: $131.657
Company Profile
- Name: Abbott Laboratories
- Website: https://www.abbottinvestor.com
- Listed Date: 1949-04-19
- Location: ABBOTT PARK, IL
- Market Status: Active
- CIK Number: 0000001800
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $225.15B
- Round Lot: 100
- Outstanding Shares: 1.74B
- Asset Type: CS
RECENT FILINGS FOR ABT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-08 | 144 | View |
| 2025-07-30 | 10-Q | View |
| 2025-07-17 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 3 | View |
| 2025-06-20 | 11-K | View |
| 2025-05-29 | SD | View |
| 2025-05-02 | 4 | View |
| 2025-05-01 | 8-K | View |
| 2025-04-30 | 144 | View |
| 2025-04-30 | 10-Q | View |
| 2025-04-29 | 4 | View |
Latest News on ABT